Accuracy of Myocardial Biomarkers in the Diagnosis of Myocardial Infarction After Revascularization as Assessed by Cardiac Resonance: The Medicine, Angioplasty, Surgery Study V (MASS-V) Trial

Autor: Cicero Piva de Albuquerque, Roberto Kalil Filho, Whady Hueb, Myrthes Emy Takiuti, Cesar Higa Nomura, Paulo Cury Rezende, Expedito Eustáquio Ribeiro da Silva, Fernando Teiichi Costa Oikawa, Eduardo Gomes Lima, Desiderio Favarato, Rodrigo Morel Vieira de Melo, José Antonio Franchini Ramires, Bernard J. Gersh, Celia Maria Cassaro Strunz, Alexandre Volney Villa, Cibele Larrosa Garzillo, Alexandre Ciappina Hueb, Leandro Menezes Alves da Costa
Rok vydání: 2016
Předmět:
Male
Pulmonary and Respiratory Medicine
medicine.medical_specialty
medicine.medical_treatment
Myocardial Infarction
Magnetic Resonance Imaging
Cine

030204 cardiovascular system & hematology
Revascularization
Sensitivity and Specificity
Severity of Illness Index
Cohort Studies
03 medical and health sciences
Percutaneous Coronary Intervention
0302 clinical medicine
Internal medicine
Angioplasty
Troponin I
medicine
Creatine Kinase
MB Form

Humans
cardiovascular diseases
030212 general & internal medicine
Myocardial infarction
Coronary Artery Bypass
Aged
Retrospective Studies
biology
business.industry
Percutaneous coronary intervention
Middle Aged
Prognosis
medicine.disease
Survival Analysis
Troponin
Surgery
Conventional PCI
cardiovascular system
Cardiology
biology.protein
Female
Creatine kinase
Cardiology and Cardiovascular Medicine
business
IMAGEM POR RESSONÂNCIA MAGNÉTICA
Biomarkers
Zdroj: Repositório Institucional da USP (Biblioteca Digital da Produção Intelectual)
Universidade de São Paulo (USP)
instacron:USP
ISSN: 0003-4975
DOI: 10.1016/j.athoracsur.2015.11.034
Popis: Background The lack of a correlation between myocardial necrosis biomarkers and electrocardiographic abnormalities after revascularization procedures has resulted in a change in the myocardial infarction (MI) definition. Methods Patients with stable multivessel disease who underwent percutaneous or surgical revascularization were included. Electrocardiograms and concentrations of high-sensitive cardiac troponin I (cTnI) and creatine kinase (CK)-MB were assessed before and after procedures. Cardiac magnetic resonance and late gadolinium enhancement were performed before and after procedures. MI was defined as more than five times the 99th percentile upper reference limit for cTnI and 10 times for CK-MB in percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG), respectively, and new late gadolinium enhancement for cardiac magnetic resonance. Results Of the 202 patients studied, 69 (34.1%) underwent on-pump CABG, 67 (33.2%) off-pump CABG, and 66 (32.7%) PCI. The receiver operating characteristic curve showed the accuracy of cTnI for on-pump CABG, off-pump CABG, and PCI patients was 21.7%, 28.3%, and 52.4% and for CK-MB was 72.5%, 81.2%, and 90.5%, respectively. The specificity of cTnI was 3.6%, 9.4%, and 42.1% and of CK-MB was 73.2%, 86.8%, and 96.4%, respectively. Sensitivity of cTnI was 100%, 100%, and 100% and of CK-MB was 69.2%, 64.3%, and 44.4%, respectively. The best cutoff of cTnI for on-pump CABG, off-pump CABG, and PCI was 6.5 ng/mL, 4.5 ng/mL, and 4.5 ng/mL (162.5, 112.5, and 112.5 times the 99th percentile upper reference limit) and of CK-MB was 37.5 ng/mL, 22.5 ng/mL, and 11.5 ng/mL (8.5, 5.1, and 2.6 times the 99th percentile upper reference limit), respectively. Conclusions Compared with cardiac magnetic resonance, CK-MB was more accurate than cTnI for diagnosing MI. These data suggest a higher troponin cutoff for the diagnosis of procedure-related MI.
Databáze: OpenAIRE